NLSP logo

NLS Pharmaceutics AG (NLSP) Cash From Operations

Annual CFO

-$9.68 M
+$4.19 M+30.22%

01 December 2023

NLSP Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NLSP Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.2%--
3 y3 years-1227.7%--
5 y5 years-254.4%--

NLSP Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1227.7%+35.2%
5 y5 years-4997.1%+35.2%
alltimeall time-4997.1%+35.2%

NLS Pharmaceutics AG Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2023
-$9.68 M(-30.2%)
-
-
Dec 2022
-$13.88 M(-7.1%)
-
-
Dec 2021
-$14.94 M(+1947.7%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
-$729.40 K(+283.9%)
-
-
Dec 2019
-$190.00 K(-93.0%)
-
-
Dec 2018
-$2.73 M(-49.7%)
-
-
Dec 2017
-$5.43 M
-
-

FAQ

  • What is NLS Pharmaceutics AG annual cash flow from operations?
  • What is the all time high annual CFO for NLS Pharmaceutics AG?
  • What is NLS Pharmaceutics AG annual CFO year-on-year change?

What is NLS Pharmaceutics AG annual cash flow from operations?

The current annual CFO of NLSP is -$9.68 M

What is the all time high annual CFO for NLS Pharmaceutics AG?

NLS Pharmaceutics AG all-time high annual cash flow from operations is -$190.00 K

What is NLS Pharmaceutics AG annual CFO year-on-year change?

Over the past year, NLSP annual cash flow from operations has changed by +$4.19 M (+30.22%)